Normal view MARC view ISBD view

Total synthesis and absolute stereochemistry of polygalolides A and B. [electronic resource]

By:

Nakamura, Seiichi

Contributor(s):

Producer: 20070122Description: 6532-5 p. digitalISSN:

1433-7851

Subject(s):

Online resources:

Available from publisher's website

In: Angewandte Chemie (International ed. in English) vol. 45

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 Immunomodulatory roles of VIP and PACAP in models of multiple sclerosis.
by Abad, Catalina
2 Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice.
by Abad, Catalina
3 Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP.
by Abad, Catalina
4 VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
by Tan, Yossan-Var
5 Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids.
by Loh, Dawn H
6 Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.
by Abad, Catalina
7 Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.
by Tan, Yossan-Var
8 VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses.
by Abad, Catalina
9 Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases.
by Couvineau, Alain
10 Vulnerability imposed by diet and brain trauma for anxiety-like phenotype: implications for post-traumatic stress disorders.
by Tyagi, Ethika
11 Pituitary adenylate-cyclase-activating polypeptide expression in the immune system.
by Abad, Catalina
12 VIP in inflammatory bowel disease: state of the art.
by Abad, Catalina
13 Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma.
by Abad, Catalina
14 Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death.
by Niewiadomski, Pawel
15 PACAP in immunity and inflammation.
by Delgado, Mario
16 Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
by Abad, Catalina
17 Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
by Abad, Catalina
18 Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.
by Arranz, Alicia
19 Restoration of axotomy-induced PACAP gene induction in SCID mice with CD4+ T-lymphocytes.
by Armstrong, Brian D
20 VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
by Abad, Catalina